BioCentury
ARTICLE | Company News

ChemBridge, Merck KGaA, Pfizer deal

February 16, 2004 8:00 AM UTC

The partners extended until 2008 a 2002 deal under which Chembridge spin-off ChemBridge Research Laboratories LLC will design and develop combinatorial compound libraries for PFE. The partners also enlarged the scope of the deal to include medicinal chemistry support for Pfizer Global Research and Development. ...